TrialClinical and experimental nephrology2015

Renoprotective effects of febuxostat in hyperuricemic patients with chronic kidney disease: a parallel-group, randomized, controlled trial.

Kenichi Tanaka et al.PubMed ↗Publisher ↗

No numbers read from the abstract.